Company & Sponsor Intelligence

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials9
Recruiting2
Completed5
Countries1

Therapeutic footprint

alzheimersanxietydementia_otherdepressionepilepsypain_neuropathyparkinsonsschizophrenia

Indexed studies

NCT04420182COVID-19 Virtual Care at Home
anxiety · Canada
NA
NCT03648749Evaluation of a Speech-to-noise Feedback Device for Treatment of Hypophonia in Parkinson's Disease
parkinsons · Canada
NA
NCT05911932Investigating Genetic Status in Patients Presenting to Clinic
alzheimers · Canada
RECRUITING
NCT04020484Making Mindfulness Matter© in Children With Epilepsy
epilepsy · Canada
NA
NCT01669967The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin
pain_neuropathy · Canada
NA
NCT04747379Psychological Effect of Explicit Recall After Sedation (PEERS)
depression · Canada
COMPLETED
NCT02945774Molecular Neuroimaging of Neuroinflammation in Neurodegenerative Dementias
dementia_other · Canada
NA
NCT00480168A Prospective Study to Assess Metabolic Changes in Children and Adolescents Treated With Atypical Antipsychotics
schizophrenia · Canada
COMPLETED
NCT03086980Automatic Self Transcending Meditation (ASTM) Versus Usual Care in Patients With Glaucoma
depression · Canada
NA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →